首页>
外国专利>
TREATMENT OF FIBROSIS WITH GENETICALLY-ENGINEERED MACROPHAGES
TREATMENT OF FIBROSIS WITH GENETICALLY-ENGINEERED MACROPHAGES
展开▼
机译:近因工程巨噬细胞治疗纤维化
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided herein are macrophages engineered for treating fibrosis and ameliorating the effects of fibrotic lesions in various organs and tissues. Certain embodiments are directed to genetically-engineered macrophages capable of treating fibrosis or reducing fibrotic lesions. In certain aspects macrophages can be genetically-engineered to (1) target extracelluar matrix (ECM) or components thereof, (2) enhance degradation of ECM, or (3) target ECM and enhance degradation of ECM. Further provided is a cellular therapy product comprising a genetically-engineered macrophage comprising at least one of a recombinant targeting protein and a recombinant catalytic enzyme. Further provided is a method of treating an individual for fibrosis comprising administering the cellular therapy product.
展开▼